# Boldo (Peumus boldus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/boldo-peumus-boldus
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 1 / 10
**Category:** South American
**Also Known As:** Peumus boldus Molina, Boldoa fragrans, Boldus boldus, Chilean boldo, boldo-do-chile, boldina (Spanish)

## Overview

Boldo leaves contain boldine (0.4–0.5% dry weight), an aporphine alkaloid that scavenges [free radical](/ingredients/condition/antioxidant)s and confers [hepatoprotective](/ingredients/condition/detox) and choleretic effects, alongside an essential oil (2–4%) rich in the toxic ascaridole (16–38%) and the [antimicrobial](/ingredients/condition/immune-support) 1,8-cineole (up to 39%). Preclinical evidence supports antioxidant, hepatoprotective, and anti-Helicobacter pylori activity attributed primarily to boldine and phenolic constituents, but no randomized controlled trials in humans have quantified therapeutic efficacy or established a standard therapeutic dose.

## Health Benefits

- **Liver and Hepatoprotection**: Boldine, the principal alkaloid, demonstrates [hepatoprotective](/ingredients/condition/detox) effects in animal models by suppressing lipid peroxidation and modulating oxidative stress pathways, helping shield hepatocytes from chemically induced injury.
- **Choleretic and Digestive Aid**: Boldo infusions stimulate bile secretion (choleretic action), facilitating fat [digestion](/ingredients/condition/gut-health) and relieving biliary discomfort; this effect is attributed to both boldine and flavonoid constituents acting on bile duct smooth muscle.
- **Antioxidant Activity**: Phenolic compounds including epigallocatechin (445 ± 37 mg/100 g in standardized extracts), catechins (304 ± 24 mg/100 g), and isorhamnetin glycosides donate electrons to neutralize [reactive oxygen species](/ingredients/condition/antioxidant), contributing significantly to overall antioxidant capacity.
- **Anti-Helicobacter pylori Activity**: Alkaloid fractions, particularly boldine and laurotetanine, exhibit in vitro inhibitory activity against Helicobacter pylori, which may partly explain the herb's traditional use for gastric complaints and ulcer prevention.
- **[Antimicrobial](/ingredients/condition/immune-support) and Antifungal Effects**: The essential oil components 1,8-cineole and ascaridole disrupt microbial membranes through lipophilic volatility, conferring broad-spectrum antimicrobial and antifungal activity demonstrated in in vitro assays.
- **[Anti-inflammatory](/ingredients/condition/inflammation) Properties**: Boldine and isorhamnetin-type flavonoids suppress pro-inflammatory mediators in preclinical models, consistent with the herb's traditional use in managing arthritis and rheumatic pain in Chilean folk medicine.
- **Mild Sedative and Antispasmodic Effects**: Alkaloid fractions, including N-methyllaurotetanine, display smooth muscle relaxant properties in animal studies, supporting traditional claims of relief from intestinal cramping and as a mild nervine.

## Mechanism of Action

Boldine (an aporphine-class alkaloid) exerts antioxidant effects primarily through direct [free radical scaveng](/ingredients/condition/antioxidant)ing—donating electrons from its catechol ring system to neutralize superoxide, hydroxyl, and peroxyl radicals—and by indirectly reducing oxidative burden through chelation of transition metals that catalyze Fenton-type reactions. [Hepatoprotect](/ingredients/condition/detox)ion is mediated via inhibition of lipid peroxidation in hepatocyte membranes and possible modulation of cytochrome P450 enzymatic activity, though specific isoform targets in humans have not been confirmed in clinical studies. Phenolic constituents (epigallocatechin, chlorogenic acid, caffeic acid, quercetin, rutin) contribute additive antioxidant and [anti-inflammatory](/ingredients/condition/inflammation) effects via inhibition of cyclooxygenase and lipoxygenase pathways, and by upregulating endogenous antioxidant enzymes such as superoxide dismutase and catalase in animal models. The essential oil constituents ascaridole and 1,8-cineole act through membrane lipid disruption and [acetylcholine](/ingredients/condition/cognitive)sterase inhibition to produce [antimicrobial](/ingredients/condition/immune-support), antiparasitic, and insecticidal effects, while ascaridole's endoperoxide structure also underlies its known hepatotoxic and neurotoxic potential at higher concentrations.

## Clinical Summary

No completed randomized controlled trials (RCTs) examining boldo in human populations with quantified efficacy endpoints have been identified in the published literature, precluding formal meta-analysis or evidence-based dosing recommendations. The totality of evidence rests on ethnopharmacological documentation, in vitro bioassays, and several rodent studies demonstrating [hepatoprotective](/ingredients/condition/detox), [antioxidant](/ingredients/condition/antioxidant), and [antimicrobial](/ingredients/condition/immune-support) activities—all of which carry well-known limitations in translating to human clinical outcomes. The EMA's 2009 assessment of Peumus boldus folium concluded that there was insufficient evidence to support a 'well-established medicinal use' designation, instead permitting a traditional use indication for mild dyspeptic complaints and minor hepatobiliary disturbances based on at least 30 years of documented use, including 15 years within the EU. Confidence in therapeutic outcomes is therefore low by evidence-based medicine standards, and practitioners should treat reported benefits as hypothesis-generating rather than clinically validated.

## Nutritional Profile

Boldo leaves are not consumed as a food staple and therefore do not contribute meaningful macronutrients (protein, fat, carbohydrate) in medicinal doses; nutritional interest centers on phytochemical constituents. Total alkaloids range from 0.25–0.7% dry weight, with boldine comprising 12–19% of the alkaloid fraction (approximately 0.4–0.5% dry weight); other alkaloids include laurotetanine and N-methyllaurotetanine at trace concentrations. Polyphenolics are significant: epigallocatechin is the dominant catechin at 445 ± 37 mg/100 g, followed by catechin at 304 ± 24 mg/100 g and epicatechin at 156 ± 12 mg/100 g in microencapsulated extracts; gallic acid, chlorogenic acid, caffeic acid, rutin, and quercetin are present at lower concentrations. Total tannins approximate 1.2% dry weight. Essential oil content is 2–4% of fresh leaf weight, composed primarily of ascaridole (16–38%), 1,8-cineole (11–39%), p-cymene (9–29%), limonene (9.1%), β-phellandrene (6.4%), terpinen-4-ol, α-terpineol, and sabinene. Bioavailability of boldine after oral ingestion is expected to be influenced by first-pass hepatic [metabolism](/ingredients/condition/weight-management) and the matrix effects of co-ingested tannins, though no formal human pharmacokinetic studies have been published.

## Dosage & Preparation

- **Dried Leaf Infusion (Tea)**: 1–2 g of comminuted dried boldo leaves in 150 mL of boiling water, steeped for 10–15 minutes; traditionally consumed 2–3 times daily before meals for digestive complaints; consistent with EMA traditional use guidance.
- **Dry Aqueous Extract (5:1 DER)**: Standardized water-extracted powder (drug-to-extract ratio 5:1), providing approximately 0.1% minimum alkaloids as boldine per European Pharmacopoeia specification; typical dose equivalent to 1–2 g crude herb.
- **Tincture (1:5, 45% ethanol)**: 2–4 mL up to three times daily; less commonly used in Europe but found in South American herbal practice; boldine and polyphenol content varies by extraction conditions.
- **Essential Oil**: Not recommended for internal use due to ascaridole toxicity (16–38% of oil); limited to topical and aromatic applications at highly diluted concentrations (≤0.5% in carrier oil).
- **Standardization Note**: European Pharmacopoeia (Ph. Eur.) mandates boldo folium contain ≥0.1% total alkaloids expressed as boldine on a dried-weight basis; commercial supplements vary widely and many lack independent verification of alkaloid content.
- **Duration**: Short-term use only (maximum 2–4 weeks continuous) is generally recommended due to cumulative ascaridole exposure risk; no long-term safety data are available.
- **Timing**: Best taken 20–30 minutes before meals to optimize choleretic and digestive effects in traditional practice.

## Safety & Drug Interactions

The primary safety concern with boldo is ascaridole, an unstable bicyclic endoperoxide monoterpene comprising 16–38% of the essential oil, which is hepatotoxic and neurotoxic in animal studies and has caused poisoning in humans when consumed as the essential oil or in excessive leaf quantities; products standardized to remove or minimize ascaridole are theoretically safer but not widely available. Boldo alkaloids, particularly boldine, have demonstrated dose-dependent cytotoxicity in vitro, and the cumulative effects of prolonged ingestion are unknown; short-term use at traditional infusion doses (1–2 g dried leaf, 2–3×/day) appears to be generally tolerated in adults, but gastrointestinal irritation and allergic reactions are plausible adverse effects. Contraindications include existing hepatobiliary disease (bile duct obstruction, liver insufficiency), pregnancy and lactation (uterotonic alkaloid activity and ascaridole fetotoxicity are documented in animal studies), and pediatric populations; the herb should not be used concurrently with hepatotoxic drugs (acetaminophen, statins, antifungal azoles) as additive liver stress is possible. No formal drug interaction studies exist, but pharmacokinetic interaction potential with CYP450-metabolized medications is plausible given boldine's preclinical modulation of hepatic oxidative enzymes; anticoagulant drugs may theoretically be affected by flavonoid constituents inhibiting platelet aggregation.

## Scientific Research

The evidence base for boldo consists almost exclusively of in vitro cell-culture studies and rodent models; no indexed randomized controlled trials in human subjects have been published as of the most recent literature searches, rendering the clinical translation of preclinical findings uncertain. Preclinical studies have demonstrated [hepatoprotective](/ingredients/condition/detox) activity in CCl₄-induced liver injury models in rats (attributed to boldine's [antioxidant](/ingredients/condition/antioxidant) and membrane-stabilizing properties), anti-H. pylori minimum inhibitory concentrations in the range of 62.5–500 µg/mL for alkaloid fractions, and antifungal activity against Candida species for the essential oil. The European Medicines Agency (EMA) monograph acknowledges boldo leaf's long-standing traditional use as a digestive and hepatic remedy and notes conformance with European Pharmacopoeia quality standards (≥0.1% total alkaloids as boldine), but explicitly classifies its medicinal use as 'traditional herbal medicinal product' rather than 'well-established use' due to the absence of adequate clinical trial data. Researchers have begun evaluating microencapsulated boldo phenolic extracts (spray-dried with maltodextrin) for stability and bioavailability in functional food applications, but pharmacokinetic data on oral bioavailability of boldine and polyphenols in humans remain unpublished in peer-reviewed literature.

## Historical & Cultural Context

Boldo has been employed in Chilean Mapuche and mestizo folk medicine for centuries, with documented use predating Spanish colonization, primarily for digestive disorders, liver complaints, bladder infections, rheumatism, and as a treatment for intestinal parasites—a use mechanistically consistent with the herb's ascaridole content, a well-characterized antihelminthic compound also found in Chenopodium ambrosioides. European colonial botanical explorers documented boldo in the 18th and 19th centuries, and the alkaloid boldine was first isolated and characterized in the early 20th century, stimulating initial pharmacological interest. Boldo leaf was officially admitted to the French Pharmacopoeia in 1884 and has been included in successive editions of the European Pharmacopoeia, reflecting its integration into Western herbal medicine well beyond its South American origins. In contemporary Chile, boldo tea (té de boldo) remains one of the most widely consumed herbal infusions for after-meal digestive support and is considered a cultural staple, with the tree itself holding symbolic importance as an emblem of Chilean native flora.

## Synergistic Combinations

Boldo is traditionally combined with cascara sagrada (Rhamnus purshiana) or senna in European and South American herbal laxative formulas, where boldo's choleretic action on bile flow complements stimulant laxative effects, producing more complete hepatobiliary and lower-GI support than either herb alone. Artichoke leaf extract (Cynara scolymus), which independently promotes bile secretion and liver cell regeneration through cynarin and luteolin, is combined with boldo in several European registered traditional herbal medicines (e.g., Boldocynara®) specifically for hepatic and digestive indications, with additive [antioxidant](/ingredients/condition/antioxidant) and choleretic mechanisms providing plausible pharmacological rationale. Dandelion root (Taraxacum officinale) provides complementary bitter and mild diuretic effects that may enhance boldo's digestive activity in dyspepsia formulas, though controlled data on any of these combinations in humans are absent.

## Frequently Asked Questions

### What is boldo leaf used for?

Boldo leaf is used traditionally as a digestive aid and liver tonic, most commonly consumed as an herbal tea (infusion of 1–2 g dried leaf) to stimulate bile flow, ease dyspepsia, and support hepatic function. Its primary active compound, boldine (an aporphine alkaloid at 0.4–0.5% dry weight), provides antioxidant and hepatoprotective effects documented in preclinical studies, while the choleretic action on bile secretion supports fat digestion. It is widely consumed in Chile for post-meal digestive discomfort and is recognized by the EMA as a traditional herbal product for mild digestive complaints.

### Is boldo safe to take daily?

Short-term daily use of boldo as a standard infusion (1–2 g dried leaves, up to 3 times per day) is generally considered tolerable in healthy adults, but long-term daily use is not recommended because the essential oil contains ascaridole (16–38%), a compound that is hepatotoxic and neurotoxic in elevated doses. No human clinical trials have established a safe maximum duration; the EMA advises limiting continuous use to no more than 2–4 weeks. Boldo is contraindicated in people with liver disease, biliary obstruction, pregnancy, lactation, or pediatric populations.

### What is boldine and what does it do?

Boldine is an aporphine alkaloid and the principal bioactive compound in boldo leaves, constituting approximately 0.4–0.5% of dried leaf weight and 75% of alkaloids in the bark. It acts as a potent free radical scavenger through its catechol ring system, reducing lipid peroxidation in hepatocyte membranes and modulating oxidative stress—effects documented in rodent models of chemically induced liver injury. Boldine also exhibits in vitro activity against Helicobacter pylori, anti-inflammatory properties, and mild smooth muscle relaxant effects, making it the compound of greatest pharmacological interest in the plant.

### Does boldo interact with any medications?

No formal clinical drug interaction studies on boldo have been published, but several theoretical interactions are relevant. Boldo's flavonoid constituents (quercetin, isorhamnetin) may inhibit platelet aggregation, potentially amplifying the effect of anticoagulant or antiplatelet drugs such as warfarin or aspirin. Because boldine may modulate hepatic cytochrome P450 enzymes in preclinical models, concurrent use with medications metabolized by CYP pathways—including statins, azole antifungals, and acetaminophen—warrants caution due to potential altered drug metabolism and additive hepatotoxic risk.

### How do you make boldo tea and how much should you drink?

Boldo tea is prepared by steeping 1–2 g of comminuted (coarsely chopped) dried boldo leaves in 150 mL of freshly boiled water for 10–15 minutes, then straining before drinking. The EMA's traditional use guidance supports consuming this preparation two to three times daily, ideally 20–30 minutes before meals to maximize the choleretic and digestive benefits. Use should be limited to short periods (2–4 weeks maximum) to minimize cumulative exposure to ascaridole, and the essential oil form should never be ingested internally due to its high ascaridole concentration and documented toxicity.

### Is boldo safe during pregnancy and breastfeeding?

Boldo is generally not recommended during pregnancy and breastfeeding due to insufficient safety data and the presence of alkaloids that may cross the placental barrier. Traditional use and animal studies suggest potential uterotonic effects, making it prudent to avoid supplementation during these periods. Consult a healthcare provider before use if you are pregnant, nursing, or planning pregnancy.

### What is the difference between boldo leaf extract and boldo tea in terms of potency?

Boldo leaf extract is typically more concentrated and bioavailable than tea, delivering higher doses of active alkaloids like boldine in smaller volumes. Boldo tea provides a gentler, more diluted form suitable for daily digestive support, while extracts are better suited for targeted hepatoprotective or choleretic effects. The choice depends on your intended use and tolerance level.

### Who should avoid taking boldo supplements?

People with bile duct obstruction, gallstones, or severe liver disease should avoid boldo due to its choleretic effects, which increase bile flow and may worsen these conditions. Those taking anticoagulants, antiplatelet agents, or medications metabolized by the liver should consult a healthcare provider, as boldine may interact with hepatic enzymes. Pregnant and nursing women should also avoid boldo supplementation.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*